Jennifer Moody

Jennifer Moody is currently the Vice President of External Innovation in Genomic Medicine at Danaher Corporation, where Jennifer is responsible for strategic collaborations with academic leaders. Jennifer also serves as a member of the Board of Directors at The Metabolomics Innovation Centre. In the past, Jennifer held various roles in market development, operations, and commercialization in companies like Pall Corporation, Morphocell Technologies, and BlueRock Therapeutics. Jennifer has a strong educational background with a PhD in Genetics from The University of British Columbia and a BSc in Genetics from York University.